AMGN vs EPAM · P/E 24, rev $10.05B vs P/E 14, rev $2.81B
Amgen Inc (AMGN) versus EPAM Systems Inc (EPAM) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Not investment advice. Open the AMGN and EPAM stock pages for the full models.
Not investment advice.